Skip to main content

Table 1 Patient characteristics

From: Effect of cryoprecipitate on an increase in fibrinogen level in patients with excessive intraoperative blood loss: a single-center retrospective study

  Group A
(n = 36)
Group B
(n = 37)
Group C
(n = 11)
p
Age (years) 62 ± 14 61 ± 18 67 ± 19 0.34
Sex (male/female) 20/16 26/11 6/5 0.37
Height (cm) 157 ± 0 160 ± 8 158 ± 7 0.25
Weight (kg) 55 ± 14 63 ± 12* 60 ± 11 0.048
ASA-PS, 1/2/3/1E/2E/3E/4E 0/2/18/0/2/13/1 0/10/16/0/1/6/4 0/3/6/1††/0/0/1 0.02
Surgery
 Cardiovascular/obstetric/other 33/2/1 30/4/3 8/2/1 0.55
Operation time (min) 426 ± 148 533 ± 212 660 ± 266** 0.002
Anesthesia time (min) 527 ± 174 643 ± 254 774 ± 307** 0.006
Intraoperative blood loss (ml) 3,348 ± 791 6,688 ± 1,225** 14,281 ± 5,142** < 0.001
Cryoprecipitate, 2/4/6 packs 33/3/0 34/2/1 7††/4††/0 0.04
  1. ASA-PS American Society of Anesthesiologists physical status classification
  2. *p < 0.05 vs. Group A, **p < 0.01 vs. Group A, p < 0.05 vs. expected value, ††p < 0.01 vs. expected value